SCHEMBL30189274

SCHEMBL30189274

O=C(O)c1cc2cc(Cl)ncc2[nH]1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F7 P08709 1/20 0.56
F3 P13726 1/20 0.56
GPR35 Q9HC97 1/20 0.51
SMAD3 P84022 1/20 0.49
HPGD P15428 5/20 0.47
KDM4E B2RXH2 4/20 0.47
HSD17B10 Q99714 3/20 0.47
ALDH1A1 P00352 2/20 0.47
LMNA P02545 2/20 0.47
TSHR P16473 2/20 0.47
CYP2C19 P33261 2/20 0.47
TDP1 Q9NUW8 2/20 0.47
PIN1 Q13526 1/20 0.47
PDPK1 O15530 1/20 0.47
NFKB1 P19838 1/20 0.47
APEX1 P27695 1/20 0.47
SRD5A2 P31213 2/20 0.47
MAPT P10636 1/20 0.47
DAO P14920 1/20 0.47
PYGL P06737 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1203070 1.00 F7 (0.56) F7F3GPR35SMAD3HPGD
SCHEMBL4721594 0.88 CHEK1 (0.44) F7F3GPR35SMAD3HPGD
SCHEMBL30189371 0.86 GPR35 (0.51) F7F3GPR35SMAD3HPGD
SCHEMBL1824752 0.86 GPR35 (0.51) F7F3GPR35SMAD3HPGD
Hydrochloric Acid SCHEMBL4400086 0.86 CHEK1 (0.43) F7F3GPR35SMAD3HPGD
SCHEMBL13271409 0.85 CCNC (0.44) F7F3GPR35LMNAPYGL
SCHEMBL13271671 0.85 CHEK1 (0.43) F7F3GPR35PIN1PYGL
SCHEMBL4268891 0.82 MEN1 (0.63) F7F3HPGDKDM4EHSD17B10
SCHEMBL2106881 0.81 PYGL (0.44) F7F3HPGDKDM4EHSD17B10
SCHEMBL1201734 0.81 KDM4E (0.53) KDM4EALDH1A1PYGLCHEK1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4161902-A1 INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF Pardes Biosciences, Inc. (US) 2023-04-12 EP disclosed
EP-4149945-A1 SUBSTITUTED TRICYCLIC AMIDES, ANALOGUES THEREOF, AND METHODS USING SAME Arbutus Biopharma Corporation (CA) 2023-03-22 EP disclosed